Dear Members,
Your Directors are pleased to present 62nd (Sixty-Second)
Integrated Annual Report of Zensar Technologies Limited ("the Company")
alongwith the Audited Financial Statements for the Financial Year ended March 31,2025.
1. FINANCIAL PERFORMANCE AND STATE OF AFFAIRS
Financial Summary
(INR Million)
Particulars |
Standalone |
Consolidated |
|
FY 2024-25 |
FY 2023-24 |
FY 2024-25 |
FY 2023-24 |
Revenue from operations |
22,261 |
20,192 |
52,806 |
49,019 |
Other Income (Net) |
3,031 |
1,726 |
1,602 |
1,588 |
Total Income |
25,292 |
21,918 |
54,408 |
50,607 |
Profit before Tax |
7,345 |
6,279 |
8,577 |
8,758 |
Profit after Tax |
5,948 |
4,770 |
6,498 |
6,650 |
On standalone basis, during FY 2024-25, the Company recorded total
income of INR 25,292 million comprising revenue from operations of INR 22,261 million and
other income of INR 3,031 million. The Company recorded a net profit of INR 5,948 million
reflecting an increase of 24.70% Y-o-Y.
On consolidated basis, the Company recorded total income of INR 54,408
million comprising revenue from operations of INR 52,806 million and other income of INR
1,602 million. The consolidated net profit was INR 6,498 million reflecting a decline of
(2.29%) Y-o-Y.
The Financial Statements are prepared in accordance with the Indian
Accounting Standards (Ind AS).
Dividend
The Board of Directors had approved an interim dividend of INR 2.00 per
share on face value of INR 2.00 each on January 22, 2025, which was paid by the Company to
the Shareholders whose names appeared in the Register of Members as on January 28, 2025,
being the record date for the payment of the interim dividend.
The Board of Directors are pleased to recommend a final dividend of INR
11.00 per share on face value of INR 2.00 each payable to those Shareholders whose names
appear in the Register of Members as on the record date set out in the AGM Notice. Thus,
the total dividend for the Financial Year 2024-25 will be INR 13.00 per share, which 650%
of face value.
The Board of Directors at its meeting held on April 25, 2025, reviewed
and revised the Dividend Distribution
Policy by including "The dividend payout ratio shall be in the
range of 40%-50% of consolidated profits. This is subject to overall performance and any
strategic initiative to be taken by the Company". The revised Dividend Distribution
Policy approved and adopted in line with Regulation 43A of the SEBI (Listing Obligations
and Disclosure Requirements) Regulations, 2015 ("the Listing Regulations") can
be accessed at https://www.zensar.com/sites/default/files/investor/
policies-reports-fillings/Dividend-Distribution-Policy.pdf
Particulars of Loans, Guarantees and Investments
pursuant to Section 186 of the Act
The particulars of loans, guarantees and investments, pursuant to
Section 186 of the Companies Act, 2013 ("the Act") are provided in the notes to
Financial Statements as per details given hereunder:
Particulars |
Relevant note |
Loan(s) |
Company has not given any loan to any parties |
Guarantee(s) |
Please refer Note No. 28 of Notes to
Financial Statements |
Investment(s) |
Please refer Note No. 5 of Notes to Financial
Statements |
Related Party Transactions
The related party transactions that were entered into during the
Financial Year 2024-25 were on an arm's length basis and were in the ordinary course of
business of the Company. The Audit Committee of the Board has granted prior omnibus
approval for the related party transactions which are of a repetitive nature. The actual
transactions
entered into, pursuant to the approval so granted, are placed
periodically before the Audit Committee.
Further, the Company has not entered into any material transaction(s)
with related parties, during the year under review, which requires reporting in Form AOC-2
in terms of the Act read with the Companies (Accounts) Rules, 2014. Flowever, the
requisite disclosures under Ind AS forms part of notes to Financial Statements.
In conformity with the requirements of the Act, read with the Listing
Regulations, the policy to deal with related party transactions is available on Company's
website and can be accessed at https://www.zensar.com/sites/
default/files/investor/policies-reports-fillings/Policy-on-
Related-Party-Transaction-14042025.pdf
Business Update
The information on Company's affairs and related aspects, are provided
under Management Discussion and Analysis Report, prepared in compliance with Regulation 34
of the Listing Regulations and forms part of this Report.
Internal financial controls and their adequacy
The details in respect of internal financial controls and their
adequacy are provided in the Management Discussion and Analysis Report, which forms part
of this report.
Transfer to Reserves
The Board does not propose to transfer any amount to general reserves
and has decided to retain the entire profit for FY 2024-25 in the profit and loss account.
Deposits
The Company has not accepted any deposits from public during the year
under review as described under Chapter V of the Act and no amount on account of principal
or interest on deposits from public was outstanding as on the date of the balance sheet.
Change in the Nature of Business
There has been no change in the nature of business of the Company
during the period under review.
Material Changes and Commitments affecting financial position between
the end of the Financial Year and date of the report
There have been no material changes and commitments which affects the
financial position of the Company that have occurred after the end of the Financial Year
ended on March 31, 2025, and the date of this report.
Significant and Material Orders passed by the Regulators or Courts or
Tribunals impacting the going concern status
There are no significant and/or material orders passed by any
Regulators/Courts/Tribunals impacting the going concern status and the Company's
operations in future.
Annual Return
In terms of Section 92(3) and Section 134(3)(a) of the Act, read with
the Companies (Management and Administration) Rules, 2014, the Annual Return of the
Company for the Financial Year ended March 31, 2025, is available on the website of the
Company and can be accessed at https://www.zensar.com/about/investors/in
vestors-relation?result=Annual-Results#lnvestor-Corner
Subsidiary Companies
The Company along with its subsidiaries provides digital solutions and
technology services globally. As of March 31,2025, the Company has 15 Subsidiaries as per
details to be set out in the Annual Return prepared under the Act.
The Board of Directors of the Company at its meeting held on July 17,
2024, accorded its consent for acquisition of 100% membership interest of Bridgeview Life
Sciences, LLC by Zensar Technologies Inc., USA, wholly owned material subsidiary of the
Company by way of execution of Share Purchase Agreement amongst Zensar Technologies Inc.,
USA and Bridgeview Life Sciences, LLC.
Foolproof Limited, UK, the wholly owned subsidiary of Zensar
Technologies (UK) Limited, had entered into a Business Transfer Agreement with Zensar
Technologies (UK) Limited on April 1,2025 whereby the entire business of Foolproof
Limited, UK has been transferred to Zensar Technologies (UK) Limited.
The highlights of performance of subsidiaries and their contribution to
the overall performance of the Company/ Group, are included in Form AOC - 1 forming part
of the Consolidated Financial Statements in this Integrated Annual Report, in accordance
with the provisions of Section 129 of the Act read with Rule 5 of the Companies (Accounts)
Rules, 2014. Further details of developments among subsidiaries during the year under
review are set out in the notes to Consolidated Financial Statements.
Policy framed by the Company for determining material subsidiaries is
available on the website of the Company and can be accessed at
https://www.zensar.com/sites/ default/files/investor/policies-reports-fillings/Policy-of-
determining-Material-Subsidiaries.pdf.
2. CORPORATE GOVERNANCE
Formal Annual Evaluation of the Board and its
Committees
The details pertaining to annual evaluation of the Board and its
Committees are provided under the Corporate Governance Report, which forms part of this
Report.
Familiarization Programme for Directors
The Company has put in place a familiarization programme for its
Directors including the Independent Directors in compliance of Regulation 25(7) of the
Listing Regulations.
The details of the familiarization programme for Independent Directors
are available on the website of the Company and can be accessed at https://www.zensar.
com/sites/default/files/investor/policies-reports-fillings/
FamiliarisationSheet-programmes.pdf
Directors' Responsibility Statement
The Directors, on the basis of information and documents made available
to them, confirm that in terms of Section 134(3)(c) of the Act:
a) in preparation of the annual accounts for the Financial Year ended
March 31,2025, the applicable accounting standards had been followed and there were no
material departures;
b) the Directors had selected such accounting policies and applied them
consistently and made judgments and estimates that are reasonable and prudent so as to
give a true and fair view of the state of affairs of the Company at the end of the
Financial Year as at March 31,2025, and of the profit of the Company for that period;
c) the Directors had taken proper and sufficient care for the
maintenance of adequate accounting records in accordance with the provisions of the Act
for safeguarding the assets of the Company and for preventing and detecting fraud and
other irregularities.
d) the Directors had prepared the annual accounts on a going concern
basis;
e) the Directors had laid down internal financial controls to be
followed by the Company and that such internal financial controls are adequate and were
operating effectively.
f) the Directors had devised proper systems to ensure compliance with
the provisions of all applicable laws and that such systems were adequate and operating
effectively.
Director(s) and Key Managerial Personnel KMP(s)
The Members of the Company at the 61st Annual General
Meeting held on August 9, 2024 had approved the re-appointment of the following Directors:
1. H. V. Goenka (DIN: 00026726), Chairman,
Non-Executive, Non-Independent Director of the Company, liable to
retire by rotation.
2. Radha Rajappa (DIN:08530439) as Non-Executive, Independent Director
of the Company for a term of 5 (five) consecutive years commencing from August 6, 2024,
till August 5, 2029 (both days inclusive).
A. T. Vaswani (DIN:00057953) superannuated as Non-Executive,
Independent Director from the close of business hours on March 31, 2025. The Board places
on record its sincere appreciation for the contribution made by A. T. Vaswani during his
tenure.
The Board of Directors of the Company, based on the recommendation of
the Nomination and Remuneration Committee and in accordance with the provisions of the Act
read with Articles of Association of the Company, recommends re-appointment of Anant
Goenka, Non-Executive, Non-Independent Director at the ensuing Annual General Meeting of
the Company (DIN: 02089850), who retires by rotation and being eligible offers himself for
re-appointment.
Key Managerial Personnel (KMP)
In terms of Section 2(51) and Section 203 of the Act following are the
Key Managerial Personnel ("KMPs") of the Company as on March 31, 2025:
Manish Tandon, Chief Executive Officer & Managing Director; Pulkit
Bhandari, Chief Financial Officer (w.e.f. August 1, 2024) and Anand Daga, Company
Secretary and Compliance Officer (w.e.f. August 8, 2024).
Sachin Zute, resigned and ceased to be the Chief Financial Officer and
Key Managerial Personnel of the Company from close of business hours on May 3, 2024.
Gaurav Tongia, resigned and ceased to be the Company Secretary, Compliance Officer and Key
Managerial Personnel of the Company from close of business hours on June 30, 2024. The
Board places on record its sincere appreciation for their contribution.
The Board of Directors on the recommendation of the Nomination and
Remuneration Committee appointed Pulkit Bhandari, as Chief Financial Officer with effect
from August 1,2024 and Anand Daga, as Company Secretary and Compliance Officer with effect
from August 8, 2024.
Board Meetings and Committees
The Board meets at regular intervals to discuss and decide on the
Company's business policy and strategy apart from other business matters. The Board met 8
(eight) times during the year, details of which are provided in the Corporate Governance
Report which forms part of this Integrated Annual Report. The intervening gap between two
meetings was within the period prescribed under the Act and the Listing Regulations.
During the year under review, the Board has accepted the recommendations of the Audit
Committee. Details of all the Committees of the Board have been given in the Corporate
Governance Report.
Statement on Declaration of Independent Directors
The Company has received necessary declaration of Independence from
Independent Directors inter-alia, pursuant to Section 149(6) and 149(7) of the Act and
under Regulation 16(1 )(b) and Regulation 25 of the Listing Regulations, confirming and
certifying that:
they have complied with all the requirements of being an
Independent Director of the Company, as on date. The certificate(s) were taken on record
by the Board, at its meeting held on April 25, 2025, after due assessment of veracity of
the same.
they possess the requisite expertise and experience and are
persons of high integrity and repute.
they have registered themselves with the Independent Directors'
Database maintained by MCA.
Risk Management
The Risk Management Committee was duly constituted by the Board in
compliance with the provisions of the Listing Regulations, details of the Committee along
with terms of reference are provided in the Corporate Governance Report which forms part
of this Integrated Annual Report.
The Company has a robust risk management framework comprising risk
governance structure and defined risk management processes. The risk governance structure
of the Company is a formal organization structure with defined roles and responsibilities
for risk management.
The processes and practices of risk management of the Company encompass
risk identification, classification, evaluation and mitigation. The Company identifies all
strategic, operational, and financial risks by assessing and analysing the latest trends
internally and externally and using it for risk management activities.
A detailed report on Risk Management is included in Management
Discussion and Analysis Report, which forms part of this Integrated Annual Report.
Secretarial Standards
The Company has devised proper systems to ensure compliance with the
provisions of Secretarial Standards (as applicable) issued by the Institute of Company
Secretaries of India and that such systems are adequate and operating effectively.
3. HUMAN RESOURCE MANAGEMENT
In compliance with the requirements of the Prevention of Sexual
Harassment of Women at the Workplace (Prevention, Prohibition and Redressal) Act, 2013
("POSH Act") and rules made thereunder, the Company has formulated and adopted a
Prevention of Sexual Harassment Policy, to provide protection and prevention to employees
at workplace and for prevention and redressal of sexual harassment complaints and
incidental matters. The Company has formulated an Internal Committee and an Anti-Sexual
Harassment Policy, to redress the complaints reported under the provisions.
The detailed report containing the details of complaints filed,
disposed of and pending during the Financial Year pertaining to sexual harassment are
provided in Corporate Governance Report which forms a part of this Integrated Annual
Report.
Employees Stock Option Plan
The Company grants share-based benefits to the eligible employees with
a view of attracting and retaining the best talent, encouraging employees to align
individual performances with the Company objectives, and promoting their increased
participation in the growth of the Company.
In compliances with the provisions of the Listing Regulations and the
SEBI (Shares Based Employee Benefits and Sweat Equity) Regulations 2021, the Company has
in place 2 (two) Employees Stock Option Schemes i.e. "2006 Employees Stock Option
Plan" ("ESOP 2006") and "Employee Performance Award Unit Plan,
2016" ("EPAP 2016"). During the year under review, the Company has amended
EPAP 2016 and revised the exercise period from 3 months to 5 years from the date of
vesting of ESOPs, after seeking approval from the shareholders of the Company.
The Nomination and Remuneration Committee at its meeting held on
January 20, 2022, resolved that no further options shall be granted under ESOP 2006.
During FY 2024-25, 28,570 equity shares and 4,47,651 equity shares were
allotted under ESOP 2006 and EPAP 2016, respectively.
The disclosure pursuant to the SEBI (Share Based Employee Benefit and
Sweat Equity) Regulations, 2021
is available on the website of the Company at https://
www.zensar.com/about/investors/investors-relation7res ult=Policies#Corporate-Governance.
Particulars of Employees
Disclosures of the ratio of the remuneration of each Director to the
median employee's remuneration and other details as required pursuant to Section 197(12)
of the Act read with Rule 5(1) of the Companies (Appointment and Remuneration of
Managerial Personnel) Rules, 2014 as amended from time to time, are provided in "Annexure
A" to this report.
The details of remuneration paid to the Directors including the Chief
Executive Officer & Managing Director of the Company are provided in the Corporate
Governance Report.
The statement containing names of top ten employees in terms of
remuneration drawn and the particulars of employees as required under Section 197(12) of
the Act read with Rule 5(2) of the Companies (Appointment and Remuneration of Managerial
Personnel) Rules, 2014 forms part of this Integrated Annual Report. However, pursuant to
the first proviso to Section 136(1) of the Act, this report is being sent to the
Shareholders excluding the aforesaid information. Any shareholder interested in obtaining
said information may write to the Company Secretary at the Registered Office of the
Company and the said information is open for inspection at the Registered Office of the
Company.
4. REPORTS AND POLICIES
Integrated Annual Report
The Company has continued its practice of developing the Integrated
Annual Report, based on the International Integrated Reporting Council's ('IIRC')
Framework, which encourages organisations to communicate their value creation over time.
The Company has embarked on this journey to communicate its integrated thinking and how
its business creates sustained value for stakeholders. The Integrated Annual Report also
encompasses aspects like strategy, performance, governance frameworks, value creation
based on various forms of capital viz. financial capital, manufactured capital,
intellectual capital, natural capital, social & relationship capital and human
capital.
Corporate Governance
The Company is committed to the highest corporate governance practices.
Pursuant to Regulation 34 read with Schedule V of the Listing Regulations, a separate
section on the Corporate Governance Report, is annexed as "Annexure B". A
certificate from Practicing Company Secretary confirming compliance with corporate
governance norms is also annexed to the Corporate Governance Report.
Management Discussion and Analysis
A detailed Management Discussion and Analysis Report is annexed to this
report as "Annexure C".
Business Responsibility and Sustainability Report
Business Responsibility and Sustainability Report prepared in
compliance with Regulation 34(2)(f) of the Listing Regulations, detailing various
initiatives taken by the Company on the environmental, social and governance front is
annexed as "Annexure D" and forms a part of this Integrated Annual
Report.
Policy on Directors'appointment and remuneration
The Company has a Nomination and Remuneration Policy (NRC Policy) for
nomination and remuneration of Directors, Key Managerial Personnel (KMP), Senior
Management Personnel (SMP) and other employees, pursuant to the Act and the Listing
Regulations, as amended from time to time.
The salient features of the Nomination and Remuneration Policy are:
1. Appointment and remuneration of Directors, KMP and SMP.
2. Determination of qualifications, positive attributes and
independence for appointment of a Director (Executive/Non-Executive/Independent) and
recommendation to the Board matters relating to the remuneration of the Directors, KMP and
SMP.
3. Formulating the criteria for performance evaluation of all
Directors.
4. Board Diversity.
The Nomination and Remuneration Policy is available on the website of
Company and can be accessed at: https://www.zensar.com/sites/default/files/investor/
policies-reports-fillings/NRC-Policy-28042025.pdf
Vigil Mechanism/Whistle Blower Policy
The Company has established a Vigil Mechanism/Whistle Blower Policy for
Directors and employees to report their genuine concerns, in compliance with Section
177(9) of the Act and Regulation 22 of the Listing Regulations. The Policy provides for
Directors and employees to report concerns about unethical behavior, actual or suspected
fraud or violation of the Company's Code of Governance and Ethics.
The policy has been communicated to the Director(s) and Employee(s) of
the Company and is also hosted on the website of the Company, which can be accessed at
https://www.zensar.com/sites/default/files/investor/
policies-reports-fillings/Whistle-Blower-Policy-and- vigil-mechanism-14042025.pdf
The Company has in place robust measures to safeguard whistle blowers
against victimisation. Directors and employees are duly sensitised about mechanisms and
guidelines for direct access to the Chairman of the Audit Committee, in appropriate cases.
Further, during FY 2024-25, no personnel has been denied access to the
Audit Committee.
5. AUDITORS AND AUDIT REPORTS
Statutory Auditors
The Company has appointed M/s. S R B C & CO LLP (ICAI Firm
Registration No. FRN 324982E/E300003), as the Statutory Auditors of the Company for a
period of 5 (Five) consecutive years, term commencing from FY 2022-23 until FY 2026-27.
The report of the Statutory Auditors on the Standalone and Consolidated
Audited Financial Statements for the Financial Year ended March 31, 2025, is annexed and
forms part of this Integrated Annual Report. The Statutory Auditors' Report does not
contain any qualifications, reservations, adverse remarks or disclaimers and hence does
not call for any comments.
Further, there was no instance of fraud reported by the Statutory
Auditors during FY 2024-25, as required under Section 134 of the Act and rules thereunder.
Secretarial Auditors and Secretarial Audit Report
The Board of Directors of the Company had appointed M/s. SVD &
Associates, Practicing Company Secretaries (Peer Review No: 669/2020) in compliance with
the provisions of Section 204 of the Act read with the Companies (Appointment and
Remuneration of Managerial Personnel) Rules, 2014, to carry out the Secretarial Audit of
the Company for the Financial Year 2024-25. The Secretarial Audit Report for the Financial
Year 2024-25, is annexed as "Annexure E" and forms part of this Report.
The Board of Directors of the Company at its meeting held on April
25,2025 proposed to appoint M/s. J. B. Bhave and Co. (CP No. 3068), Practicing Company
Secretary, as the Secretarial Auditors of the Company for a term of 5 (five) consecutive
years, to hold office from Financial Year 2025-26 till Financial Year 2029-30. The
resolution seeking your approval for the appointment and remuneration payable to M/s. J.
B. Bhave and Co. as the Secretarial Auditors forms part of the Notice convening the 62nd
(Sixty-Second) AGM of the Company.
Further, M/s. J. B. Bhave and Co. in compliance with SEBI Circular
SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31, 2024, have furnished a certificate
of their eligibility and consent for the said appointment. They have
further confirmed that the said appointment, if made, would be within the prescribed
limits and that they are not disqualified for the appointment and hold a valid certificate
issued by the Peer Review Board of the Institute of Company Secretaries of India. The
Board recommends to seek the consent from the Members on proposed appointment of M/s. J.
B. Bhave and Co. as the Secretarial Auditors for term of 5 (five) consecutive years, to
examine and audit the secretarial records of the Company.
Internal Auditors
The Board had appointed KPMG Assurance and Consulting Services LLP as
Internal Auditors for FY 2024-25 under Section 138 of the Act. Their appointment continues
for FY 2025-26.
Cost Records
The Company is not required to maintain cost records, as specified
under Section 148 of the Act.
6. CORPORATE SOCIAL RESPONSIBILITY (CSR)
In accordance with the requirements of Section 135 of the Act and Rules
framed thereunder, the Company has formulated a CSR Policy which is available on the
Company's website and can be accessed at
https://www.zensar.com/sites/default/files/investor/
policies-reports-fillinqs/CSR-Policy-14042025.pdf
Further, the CSR activities of the Company were undertaken through RPG
Foundation. Detailed information about composition of the Committee, meetings held, and
attendance, etc. along with the details of the Corporate Social Responsibility Policy
developed and implemented by the Company and CSR initiatives taken during the Financial
Year pursuant to Section 135 of the Act, is provided in "Annexure F" of
this report, which forms part of this Integrated Annual Report.
7. CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION
AND FOREIGN EXCHANGE EARNINGS AND OUTGO
The provisions relating to disclosure of details regarding energy
consumption, both total and per unit of production, are not applicable to the Company, as
the Company is engaged in the services sector and provides IT and IT related services.
Particulars prescribed under Section 134(3)(m) of the Act, read with
the Companies (Accounts) Rules, 2014 in respect of Technology Absorption, Foreign Exchange
earnings and outgo as on March 31, 2025, and R&D expenditure during the Financial Year
are set below:
Part A
Conservation of energy and water
At Zensar the energy and water management take the top most priority.
This involves proactively monitoring, controlling, and optimizing energy consumption and
planning, distribution, and efficient use of water resources to reduce costs and
environmental impact. Zensar has set stringent targets for reduction of energy
consumption, improving energy efficiency by implementing energy conservation practices,
optimization of infrastructure footprints, leveraging renewable energy sources and
monitoring the water received, consumed and recycled daily.
Zensar follows ISO 50001:2018, and has established an Energy Management
System (EnMS) to systematically optimize energy performance and promote efficient energy
management and reduce costs.
Zensar facilities have been designed with a globally accepted benchmark
for design, construction, and operation of high performance, and the infrastructure is
energy efficient. Further, the systems and equipment's are frequently
upgraded/transitioned/tailored to conserve energy and meet the current needs.
Zensar has adopted concerted efforts at every level to reduce water
consumption. The Company operates 150 KLD Sewage treatment plant for treatment of
wastewater. The Company also has 13 rainwater harvesting pits for groundwater recharging
at Pune campus. Several measurement and control devices are installed across touch-points
in all our offices to reduce water flow. Further, water leak detection and repair are
carried out at regular intervals to avoid water wastage. Zensar's Pune campus has been
water positive for the last three years.
Water management:
Water management involves the planning, distribution, and efficient use
of water resources, encompassing activities like water treatment, water distribution,
ground water recharge and managing water quality. The main source of water for Zensar
offices is through the local municipal corporation and for leased premises through the
building owners. We monitor the water received, consumed and recycled daily. Water quality
is managed by protecting water from contamination to ensure water is safe for human
consumption and other uses. Water is tested at NABL accredited laboratory. Water
distribution for domestic, drinking, cleaning, washing, flushing, canteen and gardening is
managed efficiently. Zensar adopted concerted efforts at every level to implement water
reduction measures in addition to 150 KLD sewage treatment plant for treatment of
wastewater and reuse it for gardening and 13 Nos. of rainwater harvesting pits for
groundwater recharging
at Pune campus, sensors cum aerators water taps, sensor-based urinal
flushes across locations to reduce flow are the additional initiatives. The water meters
are installed for all the buildings and daily consumption is monitored to ensure abnormal
patterns. The water leak detection and repair are carried out at regular intervals to
avoid water wastage.
FY 2024-25, the capital expenditure (capex) investments of INR 15.22
million have been made for the Carport Solar, purchase of LED lights, energy & water
conservation and AC replacements/retrofit, etc.
Part B
Technology Absorption
As a digital solutions and technology services major, our robust
innovative capabilities and intellectual property (IP) form the strategic pillars of our
solutions. Our knowledge-based intangibles lend us a competitive edge over other players.
Additionally, we make substantia I investments in research and development to cater to the
unfulfilled needs of our clients. Our innovative approach, combined with these strategic
pillars, ensures that our solutions are future-ready, making us the preferred partner of
our clients.
Zenlabs, the R&D centre, focusses on applied research in the areas
of Al, Generative Al, Cloud, Data and legacy modernization.
The expenditure incurred on Research and Development during the FY
2024-25 was INR 120 million.
PartC
Foreign Exchange Earnings and Outgo for FY 2024-25
(INR in Million)
Earnings |
21,676 |
Outgo |
263 |
8. OTHER DISCLOSURES
I. Key initiatives with respect to stakeholder relationship, customer
relationship, environment, sustainability, health and safety have been disclosed under
respective heads of Corporate Governance Report and Business Responsibility Report.
II. Noapplication has been made underthe Insolvency and Bankruptcy
Code; hence the requirement to disclose the details of application made or any proceeding
pending under the Insolvency and Bankruptcy Code, 2016 (31 of 2016) during the Financial
Year along with their status as at the end of the Financial Year is not applicable.
III. The requirement to disclose the details of difference between
amount of the valuation done at the time
of onetime settlement and the valuation done while taking loan from the
Banks or Financial Institutions along with the reasons thereof, is not applicable.
9. CAUTIONARY STATEMENT
The statements made in this report and Management Discussion and
Analysis Report relating tothe Company's objectives, projections, outlook, expectations
and others may be "forward looking statements" within the meaning of applicable
laws and regulations. Actual results may differ from expectations those expressed or
implied. Some factors could make difference to the Company's operations that may be, due
to change in government
policies, global market conditions, foreign exchange fluctuations,
natural disasters etc.
10. ACKNOWLEDGEMENTS AND APPRECIATIONS
The Directors place on record their appreciation for the continued
co-operation extended by all stakeholders including various departments of Central and
State Government, Shareholders, Investors, Bankers, Financial Institutions, Customers,
Dealers and Suppliers.
The Board also places on record its gratitude and appreciation of the
commitment and hard work put in by the Management and the employees of the Company, its
subsidiaries and associates.
|
For and on behalf of the Board of
Directors |
Place: Mumbai |
H. V. Goenka |
Dated: April 25, 2025 |
Chairman |